To improve the understanding of how genetic variations and biological mechanisms are involved in COVID-19 severity, we consider that the association of case fatality rate and genetic variants of ACE/ACE polymorphism could represent a strategy to identify possible SNPs as susceptibility and prognostic markers in the Mexican population. The gene discussed is ACE; the disease is COVID-19.